Colon cancer associated genes exhibit signatures of positive selection at functionally significant positions

BackgroundCancer, much like most human disease, is routinely studied by utilizing model organisms. Of these model organisms, mice are often dominant. However, our assumptions of functional equivalence fail to consider the opportunity for divergence conferred by ~180 Million Years (MY) of independent evolution between these species. For a given set of human disease related genes, it is therefore important to determine if functional equivalency has been retained between species. In this study we test the hypothesis that cancer associated genes have different patterns of substitution akin to adaptive evolution in different mammal lineages.ResultsOur analysis of the current literature and colon cancer databases identified 22 genes exhibiting colon cancer associated germline mutations. We identified orthologs for these 22 genes across a set of high coverage (>6X) vertebrate genomes. Analysis of these orthologous datasets revealed significant levels of positive selection. Evidence of lineage-specific positive selection was identified in 14 genes in both ancestral and extant lineages. Lineage-specific positive selection was detected in the ancestral Euarchontoglires and Hominidae lineages for STK11, in the ancestral primate lineage for CDH1, in the ancestral Murinae lineage for both SDHC and MSH6 genes and the ancestral Muridae lineage for TSC1.ConclusionIdentifying positive selection in the Primate, Hominidae, Muridae and Murinae lineages suggests an ancestral functional shift in these genes between the rodent and primate lineages. Analyses such as this, combining evolutionary theory and predictions - along with medically relevant data, can thus provide us with important clues for modeling human diseases.

[1]  J. Pritchard,et al.  A Map of Recent Positive Selection in the Human Genome , 2006, PLoS biology.

[2]  R. Nielsen,et al.  Evaluation of an improved branch-site likelihood method for detecting positive selection at the molecular level. , 2005, Molecular biology and evolution.

[3]  Kimiyoshi Arimura,et al.  Spinocerebellar ataxia with axonal neuropathy. , 2010, Advances in experimental medicine and biology.

[4]  J. Gnarra,et al.  Identification of the von Hippel-Lindau disease tumor suppressor gene. , 1993, Science.

[5]  Ziheng Yang,et al.  PAML: a program package for phylogenetic analysis by maximum likelihood , 1997, Comput. Appl. Biosci..

[6]  M. Stratton,et al.  A serine/threonine kinase gene defective in Peutz–Jeghers syndrome , 1998, Nature.

[7]  Y. Nakamura,et al.  Nine novel germline mutations of STK11 in ten families with Peutz-Jeghers syndrome , 1998, Human Genetics.

[8]  Lee,et al.  Frequent somatic mutations in serine/threonine kinase 11/Peutz-Jeghers syndrome gene in left-sided colon cancer. , 1998, Cancer research.

[9]  J. Ku,et al.  Germline mutations of E-cadherin gene in Korean familial gastric cancer patients , 1999, Journal of Human Genetics.

[10]  Scott E. Kern,et al.  DPC4, A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1 , 1996, Science.

[11]  A. Eyre-Walker,et al.  The genomic rate of adaptive amino acid substitution in Drosophila. , 2004, Molecular biology and evolution.

[12]  Jacques Ferlay,et al.  GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 [Internet] , 2013 .

[13]  R. Fleischmann,et al.  Mutations of two P/WS homologues in hereditary nonpolyposis colon cancer , 1994, Nature.

[14]  Xiao Zhen Zhou,et al.  Telomeric Protein Pin2/TRF1 as an Important ATM Target in Response to Double Strand DNA Breaks* , 2001, The Journal of Biological Chemistry.

[15]  M. Nachman,et al.  Nucleotide Variation in Wild and Inbred Mice , 2007, Genetics.

[16]  W. Murphy,et al.  Resolution of the Early Placental Mammal Radiation Using Bayesian Phylogenetics , 2001, Science.

[17]  Heather J. Ruskin,et al.  A Manually Curated Novel Knowledge Management System for Genetic and Epigenetic Molecular Determinants of Colon Cancer , 2010 .

[18]  C. Ó’Fágáin,et al.  Functional consequence of positive selection revealed through rational mutagenesis of human myeloperoxidase. , 2012, Molecular biology and evolution.

[19]  Joaquín Dopazo,et al.  Positive Selection, Relaxation, and Acceleration in the Evolution of the Human and Chimp Genome , 2006, PLoS Comput. Biol..

[20]  Rodrigo Lopez,et al.  Multiple sequence alignment with the Clustal series of programs , 2003, Nucleic Acids Res..

[21]  S. Gruber,et al.  Microsatellite instability in colorectal cancer—the stable evidence , 2010, Nature Reviews Clinical Oncology.

[22]  Nick Goldman,et al.  Accuracy and Power of Statistical Methods for Detecting Adaptive Evolution in Protein Coding Sequences and for Identifying Positively Selected Sites , 2004, Genetics.

[23]  P. Radice,et al.  Mean age of tumor onset in hereditary nonpolyposis colorectal cancer (HNPCC) families correlates with the presence of mutations in DNA mismatch repair genes , 1997, Genes, chromosomes & cancer.

[24]  K. Bjornson,et al.  Nucleotide-promoted Release of hMutSα from Heteroduplex DNA Is Consistent with an ATP-dependent Translocation Mechanism* , 1998, The Journal of Biological Chemistry.

[25]  Ulrich Müller,et al.  Mutations in SDHC cause autosomal dominant paraganglioma, type 3 , 2000, Nature Genetics.

[26]  Z. Yang,et al.  Accuracy and power of the likelihood ratio test in detecting adaptive molecular evolution. , 2001, Molecular biology and evolution.

[27]  Hongbo Zhao,et al.  Unglycosylation at Asn-633 made extracellular domain of E-cadherin folded incorrectly and arrested in endoplasmic reticulum, then sequentially degraded by ERAD , 2008, Glycoconjugate Journal.

[28]  H. Hollema,et al.  A role for MLH3 in hereditary nonpolyposis colorectal cancer , 2001, Nature Genetics.

[29]  Ailan Guo,et al.  The function of PML in p53-dependent apoptosis , 2000, Nature Cell Biology.

[30]  K. Kinzler,et al.  Cancer genes and the pathways they control , 2004, Nature Medicine.

[31]  B. Vogelstein,et al.  GermlineSMAD4 orBMPRIA mutations and phenotype of juvenile polyposis , 2002, Annals of Surgical Oncology.

[32]  H. Hollema,et al.  Molecular and clinical characteristics of MSH6 variants: an analysis of 25 index carriers of a germline variant. , 2002, American journal of human genetics.

[33]  J. Tytell,et al.  Germ-line msh6 mutations in colorectal cancer families. , 1999, Cancer research.

[34]  S. Sawyer.  Statistical tests for detecting gene conversion. , 1989, Molecular biology and evolution.

[35]  Yoichi Taya,et al.  Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2 , 2002, Nature Cell Biology.

[36]  R. Nielsen,et al.  Likelihood models for detecting positively selected amino acid sites and applications to the HIV-1 envelope gene. , 1998, Genetics.

[37]  M. Benton,et al.  Paleontological evidence to date the tree of life. , 2006, Molecular biology and evolution.

[38]  Heinz Höfler,et al.  Mutations of the human E‐cadherin (CDH1) gene , 1998, Human mutation.

[39]  J. Jiricny,et al.  Mechanisms of pathogenicity in human MSH2 missense mutants , 2008, Human mutation.

[40]  Hans Clevers,et al.  MO25α/β interact with STRADα/β enhancing their ability to bind, activate and localize LKB1 in the cytoplasm , 2003 .

[41]  D. Evans,et al.  An extended Li-Fraumeni kindred with gastric carcinoma and a codon 175 mutation in TP53. , 1995, Journal of medical genetics.

[42]  C. Ó’Fágáin,et al.  The phylogeny of the mammalian heme peroxidases and the evolution of their diverse functions , 2008, BMC Evolutionary Biology.

[43]  C. Sutter,et al.  Eight novel MSH6 germline mutations in patients with familial and nonfamilial colorectal cancer selected by loss of protein expression in tumor tissue , 2004, Human mutation.

[44]  Daniel J. Gaffney,et al.  Quantifying the slightly deleterious mutation model of molecular evolution. , 2002, Molecular biology and evolution.

[45]  J. Kładny,et al.  Germline MSH2 and MLH1 mutational spectrum including large rearrangements in HNPCC families from Poland (update study) , 2005, Clinical genetics.

[46]  J. Rossant,et al.  The Tumor Suppressor Gene Brca1 Is Required for Embryonic Cellular Proliferation in the Mouse , 1996, Cell.

[47]  Ziheng Yang.  PAML 4: phylogenetic analysis by maximum likelihood. , 2007, Molecular biology and evolution.

[48]  R. Hofstra,et al.  Two mismatch repair gene mutations found in a colon cancer patient – which one is pathogenic? , 2003, Human Genetics.

[49]  M. Kulesz-Martin,et al.  p53 protein at the hub of cellular DNA damage response pathways through sequence-specific and non-sequence-specific DNA binding. , 2001, Carcinogenesis.

[50]  E. Record,et al.  Tracking the connection between evolutionary and functional shifts using the fungal lipase/feruloyl esterase A family , 2006, BMC Evolutionary Biology.

[51]  H C Clevers,et al.  Activation of the tumour suppressor kinase LKB1 by the STE20‐like pseudokinase STRAD , 2003, The EMBO journal.

[52]  Rodrigo Lopez,et al.  Clustal W and Clustal X version 2.0 , 2007, Bioinform..

[53]  J. Saurin,et al.  Prevalence of germline mutations of hMLH1, hMSH2, hPMS1, hPMS2, and hMSH6 genes in 75 French kindreds with nonpolyposis colorectal cancer , 1999, Human Genetics.

[54]  Damian Smedley,et al.  Ensembl 2005 , 2004, Nucleic Acids Res..

[55]  T. Hubbard,et al.  A census of human cancer genes , 2004, Nature Reviews Cancer.

[56]  T. Kunkel,et al.  Direct visualization of asymmetric adenine-nucleotide-induced conformational changes in MutL alpha. , 2008, Molecular cell.

[57]  A. MacColl.  The ecological causes of evolution. , 2011, Trends in ecology & evolution.

[58]  Ş. Güran,et al.  Hereditary TP53 codon 292 and somatic P16INK4A codon 94 mutations in a Li-Fraumeni syndrome family. , 1999, Cancer genetics and cytogenetics.

[59]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[60]  David J. Kwiatkowski,et al.  Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[61]  R. Roeder,et al.  Ordered Cooperative Functions of PRMT1, p300, and CARM1 in Transcriptional Activation by p53 , 2004, Cell.

[62]  D. Ward,et al.  Mutation in the DNA mismatch repair gene homologue hMLH 1 is associated with hereditary non-polyposis colon cancer , 1994, Nature.

[63]  V. Simon,et al.  dN/dS-based methods detect positive selection linked to trade-offs between different fitness traits in the coat protein of potato virus Y. , 2011, Molecular biology and evolution.

[64]  M. Wigler,et al.  The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins , 1990, Cell.

[65]  R. Nielsen,et al.  Effect of recombination on the accuracy of the likelihood method for detecting positive selection at amino acid sites. , 2003, Genetics.

[66]  H. Bartsch,et al.  International Agency for Research on Cancer. , 1969, WHO chronicle.

[67]  Maria Merino,et al.  Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndrome. , 2002, Cancer cell.

[68]  W. Wong,et al.  Bayes empirical bayes inference of amino acid sites under positive selection. , 2005, Molecular biology and evolution.

[69]  K. Stoeber,et al.  Two ubiquitin ligases, APC/C-Cdh1 and SKP1-CUL1-F (SCF)-β-TrCP, sequentially regulate glycolysis during the cell cycle , 2011, Proceedings of the National Academy of Sciences.

[70]  E. Somers.  International Agency for Research on Cancer. , 1985, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[71]  Steven P Gygi,et al.  A probability-based approach for high-throughput protein phosphorylation analysis and site localization , 2006, Nature Biotechnology.

[72]  P. Keightley,et al.  Estimating the rate of adaptive molecular evolution in the presence of slightly deleterious mutations and population size change. , 2009, Molecular biology and evolution.

[73]  María Martín,et al.  Ongoing and future developments at the Universal Protein Resource , 2010, Nucleic Acids Res..

[74]  J. Bujnicki,et al.  Identification of Lynch syndrome mutations in the MLH1–PMS2 interface that disturb dimerization and mismatch repair , 2010, Human mutation.

[75]  W. Bodmer,et al.  hMLH1 and hMSH2 mutations in families with familial clustering of gastric cancer and hereditary non-polyposis colorectal cancer. , 2001, Cancer detection and prevention.

[76]  A. E. Hirsh,et al.  Evolutionary Rate in the Protein Interaction Network , 2002, Science.

[77]  Hans C Clevers,et al.  MO25alpha/beta interact with STRADalpha/beta enhancing their ability to bind, activate and localize LKB1 in the cytoplasm. , 2003, The EMBO journal.

[78]  Jianzhi Zhang,et al.  Why are some human disease-associated mutations fixed in mice? , 2003, Trends in genetics : TIG.

[79]  Mouse Genome Sequencing Consortium.  Initial sequencing and comparative analysis of the mouse genome , 2002, Nature.

[80]  R. Bush,et al.  Predicting adaptive evolution , 2001, Nature Reviews Genetics.

[81]  Eugene Berezikov,et al.  CONREAL web server: identification and visualization of conserved transcription factor binding sites , 2005, Nucleic Acids Res..

[82]  K. Bjornson,et al.  DNA-dependent Activation of the hMutSα ATPase* , 1998, The Journal of Biological Chemistry.

[83]  G. Parmigiani,et al.  The Consensus Coding Sequences of Human Breast and Colorectal Cancers , 2006, Science.

[84]  R. Nielsen,et al.  Patterns of Positive Selection in Six Mammalian Genomes , 2008, PLoS genetics.

[85]  A. Dean,et al.  Pervasive Cryptic Epistasis in Molecular Evolution , 2010, PLoS genetics.

[86]  Peter M Visscher,et al.  Recent human effective population size estimated from linkage disequilibrium. , 2007, Genome research.

[87]  G. Guanti,et al.  Hereditary colorectal cancer syndromes. , 2000, Acta chirurgica Iugoslavica.

[88]  H. Yamamoto,et al.  Germline and somatic mutations in hMSH6 and hMSH3 in gastrointestinal cancers of the microsatellite mutator phenotype. , 2001, Gene.

[89]  S. Nishizuka,et al.  Inactivation of the E‐Cadherin Gene in Primary Gastric Carcinomas and Gastric Carcinoma Cell Lines , 1996, Japanese journal of cancer research : Gann.

[90]  J. Lubiński,et al.  Novel mutations in the LKB1/STK11 gene in Dutch Peutz‐Jeghers families , 1999, Human mutation.

[91]  J. Tazi,et al.  A large fraction of unclassified variants of the mismatch repair genes MLH1 and MSH2 is associated with splicing defects , 2008, Human mutation.

[92]  G. Serban,et al.  A presenilin‐1/γ‐secretase cleavage releases the E‐cadherin intracellular domain and regulates disassembly of adherens junctions , 2002, The EMBO journal.

[93]  Philip Lijnzaad,et al.  The Ensembl genome database project , 2002, Nucleic Acids Res..